Expertise in
4
conditions

Ming F. Liu

Guangzhou, CN 
Expertise in
4
conditions
Guangzhou, CN 

Overview

Ming Liu practices practicing medicine in Guangzhou, China.

Liu is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Stroke, Cerebral Amyloid Angiopathy, Stomach Cancer, Thrombectomy, and Craniectomy.

They are actively involved in clinical research, co-authoring 327 peer reviewed articles and participating in 1 clinical trial.

Locations

Guangzhou, China
Other Locations
Chengdu, China
Zhanjiang, 524091, China
Key Laboratory Of Textile Fiber And Products Ministry Of Education, Wuhan, 430200, China
Zhuhai, China
Macao, 999078, China
Dazhou, China
China Resources Land Limited, Huizhou, 516000, China
Yaan, 625014, China
Siping, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of AK104 Plus Oxaliplatin and Capecitabine (XELOX) Versus Placebo Plus XELOX as First-line Treatment for Locally Advanced Unresectable or G/GEJ Adenocarcinoma
A Randomized, Double-blind, Multicenter, Phase III Study Comparing the Efficacy and Safety of AK104 Plus Oxaliplatin and Capecitabine (XELOX) Versus Placebo Plus XELOX as First-line Treatment for Locally Advanced Unresectable or G/GEJ Adenocarcinoma
Enrollment Status: Completed
Publish Date: November 19, 2025
Intervention Type: Drug
Study Drug: AK104
Study Phase: Phase 3

327 Total Publications

Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer: A Randomized Clinical Trial.
Adjuvant Chemoradiotherapy or Chemotherapy After D2 Gastrectomy in Gastric Cancer: A Randomized Clinical Trial.
Journal: JAMA network open
Published: June 15, 2026

Frequently Asked Questions about Ming F. Liu

Is Ming F. Liu a top-rated expert for Stroke?

MediFind is an objective health platform that identifies experts based on real-world data. Ming F. Liu is classified as an Distinguished expert for Stroke, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ming F. Liu participate in research or clinical trials?

Yes. Ming F. Liu has published 327 articles and abstracts on conditions like Stroke. You can view a list of Ming F. Liu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Liu's expertise for a condition
ConditionClose
    View All 27 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile